Quarterly report [Sections 13 or 15(d)]

SEGMENT INFORMATION

v3.25.1
SEGMENT INFORMATION
3 Months Ended
Mar. 31, 2025
SEGMENT INFORMATION  
SEGMENT INFORMATION

13.Segment Information

We view our operations and manage our business as one operating segment, and our chief operating decision maker (CODM) is our chief executive officer. The following table presents segment information for the periods presented:

Three Months Ended March 31, 

2025

2024

(in thousands)

Total Revenues

$

53,333

$

29,534

Less:

Employee related expenses

19,538

19,367

Commercial related expenses

5,339

5,109

Outside clinical trial related expenses

4,371

2,512

Cost of product sales

4,409

2,025

Consultants and third-party services

3,409

4,343

Other segment items

3,494

3,144

Interest expense, net

1,262

1,281

Provision for income taxes

65

Segment income (loss)

$

11,446

$

(8,247)

There is no reconciling items or adjustments between segment income (loss) presented above and net income (loss) as presented in our statements of operations. The CODM does not review assets in evaluating the segment results and therefore such information is not presented.

For details of revenues disaggregated by category, see “Note 3 – Revenues.”

Employee related expenses primarily comprised salaries, employee benefits, other employee related expenses and stock-based compensation expense. For details of stock-based compensation expense, see “Note 6 – Stock-Based Compensation.” Other segment items for the periods presented primarily comprised travel related expenses, business insurance, taxes and licenses, and facility related expenses.